1 Study Coverage 1.1 Lipids Active Pharmaceutical Ingredient Product Introduction 1.2 Market by Type 1.2.1 Global Lipids Active Pharmaceutical Ingredient Market Size Growth Rate by Type 1.2.2 Simple Lipids 1.2.3 Compound Lipids 1.2.4 Derived Lipids 1.3 Market by Application 1.3.1 Global Lipids Active Pharmaceutical Ingredient Market Size Growth Rate by Application 1.3.2 Cardiovascular Disease 1.3.3 Inflammatory Diseases 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Lipids Active Pharmaceutical Ingredient Market Size, Estimates and Forecasts 2.1.1 Global Lipids Active Pharmaceutical Ingredient Revenue 2016-2027 2.1.2 Global Lipids Active Pharmaceutical Ingredient Sales 2016-2027 2.2 Global Lipids Active Pharmaceutical Ingredient, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Lipids Active Pharmaceutical Ingredient Historical Market Size by Region (2016-2021) 2.3.1 Global Lipids Active Pharmaceutical Ingredient Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Lipids Active Pharmaceutical Ingredient Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Lipids Active Pharmaceutical Ingredient Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Lipids Active Pharmaceutical Ingredient Sales Forecast by Region (2022-2027) 2.4.2 Global Lipids Active Pharmaceutical Ingredient Revenue Forecast by Region (2022-2027) 3 Global Lipids Active Pharmaceutical Ingredient Competitor Landscape by Players 3.1 Global Top Lipids Active Pharmaceutical Ingredient Manufacturers by Sales 3.1.1 Global Lipids Active Pharmaceutical Ingredient Sales by Manufacturer (2016-2021) 3.1.2 Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Lipids Active Pharmaceutical Ingredient Manufacturers by Revenue 3.2.1 Key Lipids Active Pharmaceutical Ingredient Manufacturers Covered: Ranking by Revenue 3.2.2 Global Lipids Active Pharmaceutical Ingredient Revenue by Manufacturers (2016-2021) 3.2.3 Global Lipids Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Lipids Active Pharmaceutical Ingredient Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Lipids Active Pharmaceutical Ingredient Revenue in 2020 3.2.6 Global Lipids Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Lipids Active Pharmaceutical Ingredient Price by Manufacturers 3.4 Global Lipids Active Pharmaceutical Ingredient Manufacturing Base Distribution, Product Types 3.4.1 Lipids Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Lipids Active Pharmaceutical Ingredient Product Type 3.4.3 Date of International Manufacturers Enter into Lipids Active Pharmaceutical Ingredient Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Lipids Active Pharmaceutical Ingredient Market Size by Type (2016-2021) 4.1.1 Global Lipids Active Pharmaceutical Ingredient Sales by Type (2016-2021) 4.1.2 Global Lipids Active Pharmaceutical Ingredient Revenue by Type (2016-2021) 4.1.3 Lipids Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Lipids Active Pharmaceutical Ingredient Market Size Forecast by Type (2022-2027) 4.2.1 Global Lipids Active Pharmaceutical Ingredient Sales Forecast by Type (2022-2027) 4.2.2 Global Lipids Active Pharmaceutical Ingredient Revenue Forecast by Type (2022-2027) 4.2.3 Lipids Active Pharmaceutical Ingredient Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Lipids Active Pharmaceutical Ingredient Market Size by Application (2016-2021) 5.1.1 Global Lipids Active Pharmaceutical Ingredient Sales by Application (2016-2021) 5.1.2 Global Lipids Active Pharmaceutical Ingredient Revenue by Application (2016-2021) 5.1.3 Lipids Active Pharmaceutical Ingredient Price by Application (2016-2021) 5.2 Lipids Active Pharmaceutical Ingredient Market Size Forecast by Application (2022-2027) 5.2.1 Global Lipids Active Pharmaceutical Ingredient Sales Forecast by Application (2022-2027) 5.2.2 Global Lipids Active Pharmaceutical Ingredient Revenue Forecast by Application (2022-2027) 5.2.3 Global Lipids Active Pharmaceutical Ingredient Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Lipids Active Pharmaceutical Ingredient Market Size YoY Growth 2016-2027 6.1.1 United States Lipids Active Pharmaceutical Ingredient Sales YoY Growth 2016-2027 6.1.2 United States Lipids Active Pharmaceutical Ingredient Revenue YoY Growth 2016-2027 6.1.3 United States Lipids Active Pharmaceutical Ingredient Market Share in Global Market 2016-2027 6.2 United States Lipids Active Pharmaceutical Ingredient Market Size by Players (International and Local Players) 6.2.1 United States Top Lipids Active Pharmaceutical Ingredient Players by Sales (2016-2021) 6.2.2 United States Top Lipids Active Pharmaceutical Ingredient Players by Revenue (2016-2021) 6.3 United States Lipids Active Pharmaceutical Ingredient Historic Market Review by Type (2016-2021) 6.3.1 United States Lipids Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2021) 6.3.2 United States Lipids Active Pharmaceutical Ingredient Revenue Market Share by Type (2016-2021) 6.3.3 United States Lipids Active Pharmaceutical Ingredient Price by Type (2016-2021) 6.4 United States Lipids Active Pharmaceutical Ingredient Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Lipids Active Pharmaceutical Ingredient Sales Forecast by Type (2022-2027) 6.4.2 United States Lipids Active Pharmaceutical Ingredient Revenue Forecast by Type (2022-2027) 6.4.3 United States Lipids Active Pharmaceutical Ingredient Price Forecast by Type (2022-2027) 6.5 United States Lipids Active Pharmaceutical Ingredient Historic Market Review by Application (2016-2021) 6.5.1 United States Lipids Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2021) 6.5.2 United States Lipids Active Pharmaceutical Ingredient Revenue Market Share by Application (2016-2021) 6.5.3 United States Lipids Active Pharmaceutical Ingredient Price by Application (2016-2021) 6.6 United States Lipids Active Pharmaceutical Ingredient Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Lipids Active Pharmaceutical Ingredient Sales Forecast by Application (2022-2027) 6.6.2 United States Lipids Active Pharmaceutical Ingredient Revenue Forecast by Application (2022-2027) 6.6.3 United States Lipids Active Pharmaceutical Ingredient Price Forecast by Application (2022-2027) 7 North America 7.1 North America Lipids Active Pharmaceutical Ingredient Market Size YoY Growth 2016-2027 7.2 North America Lipids Active Pharmaceutical Ingredient Market Facts & Figures by Country 7.2.1 North America Lipids Active Pharmaceutical Ingredient Sales by Country (2016-2021) 7.2.2 North America Lipids Active Pharmaceutical Ingredient Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Lipids Active Pharmaceutical Ingredient Market Size YoY Growth 2016-2027 8.2 Asia Pacific Lipids Active Pharmaceutical Ingredient Market Facts & Figures by Region 8.2.1 Asia Pacific Lipids Active Pharmaceutical Ingredient Sales by Region (2016-2021) 8.2.2 Asia Pacific Lipids Active Pharmaceutical Ingredient Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Lipids Active Pharmaceutical Ingredient Market Size YoY Growth 2016-2027 9.2 Europe Lipids Active Pharmaceutical Ingredient Market Facts & Figures by Country 9.2.1 Europe Lipids Active Pharmaceutical Ingredient Sales by Country (2016-2021) 9.2.2 Europe Lipids Active Pharmaceutical Ingredient Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Lipids Active Pharmaceutical Ingredient Market Size YoY Growth 2016-2027 10.2 Latin America Lipids Active Pharmaceutical Ingredient Market Facts & Figures by Country 10.2.1 Latin America Lipids Active Pharmaceutical Ingredient Sales by Country (2016-2021) 10.2.2 Latin America Lipids Active Pharmaceutical Ingredient Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Lipids Active Pharmaceutical Ingredient Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Lipids Active Pharmaceutical Ingredient Market Facts & Figures by Country 11.2.1 Middle East and Africa Lipids Active Pharmaceutical Ingredient Sales by Country (2016-2021) 11.2.2 Middle East and Africa Lipids Active Pharmaceutical Ingredient Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 CordenPharma International 12.1.1 CordenPharma International Corporation Information 12.1.2 CordenPharma International Description and Business Overview 12.1.3 CordenPharma International Lipids Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.1.4 CordenPharma International Lipids Active Pharmaceutical Ingredient Products Offered 12.1.5 CordenPharma International Recent Development 12.2 Avanti Polar Lipids 12.2.1 Avanti Polar Lipids Corporation Information 12.2.2 Avanti Polar Lipids Description and Business Overview 12.2.3 Avanti Polar Lipids Lipids Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Avanti Polar Lipids Lipids Active Pharmaceutical Ingredient Products Offered 12.2.5 Avanti Polar Lipids Recent Development 12.3 VAV Life Sciences 12.3.1 VAV Life Sciences Corporation Information 12.3.2 VAV Life Sciences Description and Business Overview 12.3.3 VAV Life Sciences Lipids Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.3.4 VAV Life Sciences Lipids Active Pharmaceutical Ingredient Products Offered 12.3.5 VAV Life Sciences Recent Development 12.4 Sancilio＆Company 12.4.1 Sancilio＆Company Corporation Information 12.4.2 Sancilio＆Company Description and Business Overview 12.4.3 Sancilio＆Company Lipids Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Sancilio＆Company Lipids Active Pharmaceutical Ingredient Products Offered 12.4.5 Sancilio＆Company Recent Development 12.5 Cayman Chemical 12.5.1 Cayman Chemical Corporation Information 12.5.2 Cayman Chemical Description and Business Overview 12.5.3 Cayman Chemical Lipids Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Cayman Chemical Lipids Active Pharmaceutical Ingredient Products Offered 12.5.5 Cayman Chemical Recent Development 12.6 Cerbios-Pharma SA 12.6.1 Cerbios-Pharma SA Corporation Information 12.6.2 Cerbios-Pharma SA Description and Business Overview 12.6.3 Cerbios-Pharma SA Lipids Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Cerbios-Pharma SA Lipids Active Pharmaceutical Ingredient Products Offered 12.6.5 Cerbios-Pharma SA Recent Development 12.7 Merck KGaA 12.7.1 Merck KGaA Corporation Information 12.7.2 Merck KGaA Description and Business Overview 12.7.3 Merck KGaA Lipids Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Merck KGaA Lipids Active Pharmaceutical Ingredient Products Offered 12.7.5 Merck KGaA Recent Development 12.8 Esperion Therapeutics 12.8.1 Esperion Therapeutics Corporation Information 12.8.2 Esperion Therapeutics Description and Business Overview 12.8.3 Esperion Therapeutics Lipids Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Esperion Therapeutics Lipids Active Pharmaceutical Ingredient Products Offered 12.8.5 Esperion Therapeutics Recent Development 12.11 CordenPharma International 12.11.1 CordenPharma International Corporation Information 12.11.2 CordenPharma International Description and Business Overview 12.11.3 CordenPharma International Lipids Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.11.4 CordenPharma International Lipids Active Pharmaceutical Ingredient Products Offered 12.11.5 CordenPharma International Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Lipids Active Pharmaceutical Ingredient Industry Trends 13.2 Lipids Active Pharmaceutical Ingredient Market Drivers 13.3 Lipids Active Pharmaceutical Ingredient Market Challenges 13.4 Lipids Active Pharmaceutical Ingredient Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Lipids Active Pharmaceutical Ingredient Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Lipids Active Pharmaceutical Ingredient Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Simple Lipids Table 3. Major Manufacturers of Compound Lipids Table 4. Major Manufacturers of Derived Lipids Table 5. Global Lipids Active Pharmaceutical Ingredient Market Size Growth Rate by Application (2021-2027) & (Kiloton) Table 6. Global Lipids Active Pharmaceutical Ingredient Market Size by Region (Kiloton) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Lipids Active Pharmaceutical Ingredient Sales by Regions (2016-2021) & (Kiloton) Table 8. Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Regions (2016-2021) Table 9. Global Lipids Active Pharmaceutical Ingredient Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Lipids Active Pharmaceutical Ingredient Sales Forecast by Region (2022-2027) & (Kiloton) Table 11. Global Lipids Active Pharmaceutical Ingredient Sales Market Share Forecast by Region (2022-2027) Table 12. Global Lipids Active Pharmaceutical Ingredient Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Lipids Active Pharmaceutical Ingredient Sales by Manufacturers (2016-2021) (Kiloton) Table 15. Global Lipids Active Pharmaceutical Ingredient Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Lipids Active Pharmaceutical Ingredient Manufacturers by Revenue (US$ Million) in 2020 Table 17. Lipids Active Pharmaceutical Ingredient Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Lipids Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2016-2021) Table 19. Global Lipids Active Pharmaceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Lipids Active Pharmaceutical Ingredient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lipids Active Pharmaceutical Ingredient as of 2020) Table 21. Key Manufacturers Lipids Active Pharmaceutical Ingredient Price (2016-2021) (US$/Ton) Table 22. Lipids Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Lipids Active Pharmaceutical Ingredient Product Type Table 24. Date of International Manufacturers Enter into Lipids Active Pharmaceutical Ingredient Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Lipids Active Pharmaceutical Ingredient Sales by Type (2016-2021) (Kiloton) Table 27. Global Lipids Active Pharmaceutical Ingredient Sales Share by Type (2016-2021) Table 28. Global Lipids Active Pharmaceutical Ingredient Revenue by Type (2016-2021) (US$ Million) Table 29. Global Lipids Active Pharmaceutical Ingredient Revenue Share by Type (2016-2021) Table 30. Lipids Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type (2016-2021) & (US$/Ton) Table 31. Global Lipids Active Pharmaceutical Ingredient Sales Forecast by Type (2022-2027) & (Kiloton) Table 32. Global Lipids Active Pharmaceutical Ingredient Sales Market Share Forecast by Type (2022-2027) Table 33. Global Lipids Active Pharmaceutical Ingredient Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Lipids Active Pharmaceutical Ingredient Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Ton) Table 36. Global Lipids Active Pharmaceutical Ingredient Sales by Application (2016-2021) (Kiloton) Table 37. Global Lipids Active Pharmaceutical Ingredient Sales Share by Application (2016-2021) Table 38. Global Lipids Active Pharmaceutical Ingredient Revenue by Application (2016-2021) (US$ Million) Table 39. Global Lipids Active Pharmaceutical Ingredient Revenue Share by Application (2016-2021) Table 40. Lipids Active Pharmaceutical Ingredient Average Selling Price (ASP) by Application (2016-2021) & (US$/Ton) Table 41. Global Lipids Active Pharmaceutical Ingredient Sales Forecast by Application (2022-2027) & (Kiloton) Table 42. Global Lipids Active Pharmaceutical Ingredient Sales Market Share Forecast by Application (2022-2027) Table 43. Global Lipids Active Pharmaceutical Ingredient Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Lipids Active Pharmaceutical Ingredient Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Ton) Table 46. United States Lipids Active Pharmaceutical Ingredient Sales (Kiloton) of Key Companies (2016-2021) Table 47. United States Lipids Active Pharmaceutical Ingredient Sales Share by Company (2016-2021) Table 48. United States Lipids Active Pharmaceutical Ingredient Revenue (US$ Million) by Company (2016-2021) Table 49. United States Lipids Active Pharmaceutical Ingredient Revenue Share by Company (2016-2021) Table 50. United States Lipids Active Pharmaceutical Ingredient Sales (Kiloton) by Type (2016-2021) Table 51. United States Lipids Active Pharmaceutical Ingredient Sales Share by Type (2016-2021) Table 52. United States Lipids Active Pharmaceutical Ingredient Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. United States Lipids Active Pharmaceutical Ingredient Price (US$/Ton) by Type (2016-2021) Table 54. United States Lipids Active Pharmaceutical Ingredient Sales (Kiloton) by Type (2022-2027) Table 55. United States Lipids Active Pharmaceutical Ingredient Sales Share by Type (2022-2027) Table 56. United States Lipids Active Pharmaceutical Ingredient Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. United States Lipids Active Pharmaceutical Ingredient Revenue Share by Type (2022-2027) Table 58. United States Lipids Active Pharmaceutical Ingredient Price (US$/Ton) by Type (2022-2027) Table 59. United States Lipids Active Pharmaceutical Ingredient Sales (Kiloton) by Application (2016-2021) Table 60. United States Lipids Active Pharmaceutical Ingredient Sales Share by Application (2016-2021) Table 61. United States Lipids Active Pharmaceutical Ingredient Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. United States Lipids Active Pharmaceutical Ingredient Price (US$/Ton) by Application (2016-2021) Table 63. United States Lipids Active Pharmaceutical Ingredient Sales (Kiloton) by Application (2022-2027) Table 64. United States Lipids Active Pharmaceutical Ingredient Sales Share by Application (2022-2027) Table 65. United States Lipids Active Pharmaceutical Ingredient Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. United States Lipids Active Pharmaceutical Ingredient Revenue Share by Application (2022-2027) Table 67. United States Lipids Active Pharmaceutical Ingredient Price (US$/Ton) by Application (2022-2027) Table 68. North America Lipids Active Pharmaceutical Ingredient Sales by Country (2016-2021) & (Kiloton) Table 69. North America Lipids Active Pharmaceutical Ingredient Sales Market Share by Country (2016-2021) Table 70. North America Lipids Active Pharmaceutical Ingredient Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Lipids Active Pharmaceutical Ingredient Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Lipids Active Pharmaceutical Ingredient Sales by Region (2016-2021) & (Kiloton) Table 73. Asia Pacific Lipids Active Pharmaceutical Ingredient Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Lipids Active Pharmaceutical Ingredient Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Lipids Active Pharmaceutical Ingredient Revenue Market Share by Region (2016-2021) Table 76. Europe Lipids Active Pharmaceutical Ingredient Sales by Country (2016-2021) & (Kiloton) Table 77. Europe Lipids Active Pharmaceutical Ingredient Sales Market Share by Country (2016-2021) Table 78. Europe Lipids Active Pharmaceutical Ingredient Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Lipids Active Pharmaceutical Ingredient Revenue Market Share by Country (2016-2021) Table 80. Latin America Lipids Active Pharmaceutical Ingredient Sales by Country (2016-2021) & (Kiloton) Table 81. Latin America Lipids Active Pharmaceutical Ingredient Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Lipids Active Pharmaceutical Ingredient Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Lipids Active Pharmaceutical Ingredient Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Lipids Active Pharmaceutical Ingredient Sales by Country (2016-2021) & (Kiloton) Table 85. Middle East and Africa Lipids Active Pharmaceutical Ingredient Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Lipids Active Pharmaceutical Ingredient Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Lipids Active Pharmaceutical Ingredient Revenue Market Share by Country (2016-2021) Table 88. CordenPharma International Corporation Information Table 89. CordenPharma International Description and Business Overview Table 90. CordenPharma International Lipids Active Pharmaceutical Ingredient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 91. CordenPharma International Lipids Active Pharmaceutical Ingredient Product Table 92. CordenPharma International Recent Development Table 93. Avanti Polar Lipids Corporation Information Table 94. Avanti Polar Lipids Description and Business Overview Table 95. Avanti Polar Lipids Lipids Active Pharmaceutical Ingredient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 96. Avanti Polar Lipids Product Table 97. Avanti Polar Lipids Recent Development Table 98. VAV Life Sciences Corporation Information Table 99. VAV Life Sciences Description and Business Overview Table 100. VAV Life Sciences Lipids Active Pharmaceutical Ingredient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 101. VAV Life Sciences Product Table 102. VAV Life Sciences Recent Development Table 103. Sancilio＆Company Corporation Information Table 104. Sancilio＆Company Description and Business Overview Table 105. Sancilio＆Company Lipids Active Pharmaceutical Ingredient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 106. Sancilio＆Company Product Table 107. Sancilio＆Company Recent Development Table 108. Cayman Chemical Corporation Information Table 109. Cayman Chemical Description and Business Overview Table 110. Cayman Chemical Lipids Active Pharmaceutical Ingredient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 111. Cayman Chemical Product Table 112. Cayman Chemical Recent Development Table 113. Cerbios-Pharma SA Corporation Information Table 114. Cerbios-Pharma SA Description and Business Overview Table 115. Cerbios-Pharma SA Lipids Active Pharmaceutical Ingredient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 116. Cerbios-Pharma SA Product Table 117. Cerbios-Pharma SA Recent Development Table 118. Merck KGaA Corporation Information Table 119. Merck KGaA Description and Business Overview Table 120. Merck KGaA Lipids Active Pharmaceutical Ingredient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 121. Merck KGaA Product Table 122. Merck KGaA Recent Development Table 123. Esperion Therapeutics Corporation Information Table 124. Esperion Therapeutics Description and Business Overview Table 125. Esperion Therapeutics Lipids Active Pharmaceutical Ingredient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 126. Esperion Therapeutics Product Table 127. Esperion Therapeutics Recent Development Table 128. Lipids Active Pharmaceutical Ingredient Market Trends Table 129. Lipids Active Pharmaceutical Ingredient Market Drivers Table 130. Lipids Active Pharmaceutical Ingredient Market Challenges Table 131. Lipids Active Pharmaceutical Ingredient Market Restraints Table 132. Lipids Active Pharmaceutical Ingredient Customers List Table 133. Lipids Active Pharmaceutical Ingredient Distributors List Table 134. Research Programs/Design for This Report Table 135. Key Data Information from Secondary Sources Table 136. Key Data Information from Primary Sources List of Figures Figure 1. Lipids Active Pharmaceutical Ingredient Product Picture Figure 2. Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Type in 2020 & 2027 Figure 3. Simple Lipids Product Picture Figure 4. Compound Lipids Product Picture Figure 5. Derived Lipids Product Picture Figure 6. Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Application in 2020 & 2027 Figure 7. Cardiovascular Disease Figure 8. Inflammatory Diseases Figure 9. Others Figure 10. Lipids Active Pharmaceutical Ingredient Report Years Considered Figure 11. Global Lipids Active Pharmaceutical Ingredient Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Lipids Active Pharmaceutical Ingredient Market Size 2016-2027 (US$ Million) Figure 13. Global Lipids Active Pharmaceutical Ingredient Sales 2016-2027 (Kiloton) Figure 14. Global Lipids Active Pharmaceutical Ingredient Market Size Market Share by Region: 2021 Versus 2027 Figure 15. Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Region (2016-2021) Figure 16. Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Region in 2020 Figure 17. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share by Region (2016-2021) Figure 18. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share by Region in 2020 Figure 19. Global Lipids Active Pharmaceutical Ingredient Sales Share by Manufacturer in 2020 Figure 20. The Top 10 and 5 Players Market Share by Lipids Active Pharmaceutical Ingredient Revenue in 2020 Figure 21. Lipids Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 22. Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Type (2016-2021) Figure 23. Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Type in 2020 Figure 24. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share by Type (2016-2021) Figure 25. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share by Type in 2020 Figure 26. Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Application (2016-2021) Figure 27. Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Application in 2020 Figure 28. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share by Application (2016-2021) Figure 29. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share by Application in 2020 Figure 30. United States Lipids Active Pharmaceutical Ingredient Sales Growth Rate 2016-2027 (Kiloton) Figure 31. United States Lipids Active Pharmaceutical Ingredient Revenue Growth Rate 2016-2027 (US$ Million) Figure 32. United States Lipids Active Pharmaceutical Ingredient Market Share in Global Market 2016-2027 Figure 33. United States 5 and 10 Largest Lipids Active Pharmaceutical Ingredient Players Market Share by Revenue in Lipids Active Pharmaceutical Ingredient in 2020 Figure 34. United States Lipids Active Pharmaceutical Ingredient Revenue Share by Type (2016-2021) Figure 35. United States Lipids Active Pharmaceutical Ingredient Revenue Growth Rate by Type in 2016 & 2020 Figure 36. United States Lipids Active Pharmaceutical Ingredient Revenue Share by Application (2016-2021) Figure 37. United States Lipids Active Pharmaceutical Ingredient Revenue Growth Rate by Application in 2016 & 2020 Figure 38. North America Lipids Active Pharmaceutical Ingredient Sales Growth Rate 2016-2021 (Kiloton) Figure 39. North America Lipids Active Pharmaceutical Ingredient Revenue Growth Rate 2016-2021 (US$ Million) Figure 40. North America Lipids Active Pharmaceutical Ingredient Sales Market Share by Country in 2020 Figure 41. North America Lipids Active Pharmaceutical Ingredient Revenue Market Share by Country in 2020 Figure 42. U.S. Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 43. U.S. Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Canada Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 45. Canada Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Europe Lipids Active Pharmaceutical Ingredient Sales Growth Rate 2016-2021 (Kiloton) Figure 47. Europe Lipids Active Pharmaceutical Ingredient Revenue Growth Rate 2016-2021 (US$ Million) Figure 48. Europe Lipids Active Pharmaceutical Ingredient Sales Market Share by Country in 2020 Figure 49. Europe Lipids Active Pharmaceutical Ingredient Revenue Market Share by Country in 2020 Figure 50. Germany Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 51. Germany Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. France Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 53. France Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. U.K. Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 55. U.K. Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Italy Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 57. Italy Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Russia Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 59. Russia Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Asia Pacific Lipids Active Pharmaceutical Ingredient Sales Growth Rate 2016-2021 (Kiloton) Figure 61. Asia Pacific Lipids Active Pharmaceutical Ingredient Revenue Growth Rate 2016-2021 (US$ Million) Figure 62. Asia Pacific Lipids Active Pharmaceutical Ingredient Sales Market Share by Region in 2020 Figure 63. Asia Pacific Lipids Active Pharmaceutical Ingredient Revenue Market Share by Region in 2020 Figure 64. China Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 65. China Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. Japan Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 67. Japan Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. South Korea Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 69. South Korea Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. India Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 71. India Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. Australia Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 73. Australia Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Taiwan Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 75. Taiwan Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Indonesia Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 77. Indonesia Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Thailand Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 79. Thailand Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Malaysia Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 81. Malaysia Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Philippines Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 83. Philippines Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Vietnam Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 85. Vietnam Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Latin America Lipids Active Pharmaceutical Ingredient Sales Growth Rate 2016-2021 (Kiloton) Figure 87. Latin America Lipids Active Pharmaceutical Ingredient Revenue Growth Rate 2016-2021 (US$ Million) Figure 88. Latin America Lipids Active Pharmaceutical Ingredient Sales Market Share by Country in 2020 Figure 89. Latin America Lipids Active Pharmaceutical Ingredient Revenue Market Share by Country in 2020 Figure 90. Mexico Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 91. Mexico Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Brazil Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 93. Brazil Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Argentina Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 95. Argentina Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 96. Middle East and Africa Lipids Active Pharmaceutical Ingredient Sales Growth Rate 2016-2021 (Kiloton) Figure 97. Middle East and Africa Lipids Active Pharmaceutical Ingredient Revenue Growth Rate 2016-2021 (US$ Million) Figure 98. Middle East and Africa Lipids Active Pharmaceutical Ingredient Sales Market Share by Country in 2020 Figure 99. Middle East and Africa Lipids Active Pharmaceutical Ingredient Revenue Market Share by Country in 2020 Figure 100. Turkey Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 101. Turkey Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. Saudi Arabia Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 103. Saudi Arabia Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. UAE Lipids Active Pharmaceutical Ingredient Sales Growth Rate (2016-2021) (Kiloton) Figure 105. UAE Lipids Active Pharmaceutical Ingredient Revenue Growth Rate (2016-2021) (US$ Million) Figure 106. Lipids Active Pharmaceutical Ingredient Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

CordenPharma International Avanti Polar Lipids VAV Life Sciences Sancilio＆Company Cayman Chemical Cerbios-Pharma SA Merck KGaA Esperion Therapeutics